Anal cancer screening results from 18‐to‐34‐year‐old men who have sex with men living with HIV
International Journal of Cancer · 2024
DOI: 10.1002/ijc.34734 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, 2024. Verfasst von Yuxin Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Hauptthemen laut MEDLINE: Papillomavirus Infections, HIV Infections, Sexual and Gender Minorities, Anus Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NCATS NIH HHS, Division of Cancer Prevention, National Cancer Institute.
Abstract (Originalsprache)
Men who have sex with men living with HIV (MSM LWH) are at highest risk for human papillomavirus (HPV)‐associated anal cancer. There is no consensus on the optimal screening initiation age. This study aimed to assess the prevalence and severity of anal HPV disease among MSM LWH under the age of 35, which is a currently proposed screening age threshold. Between 2014 and 2020, 1255 18‐to‐34‐year‐old MSM LWH underwent anal cytology screening. 916 were co‐tested for high‐risk HPV (HR‐HPV). 467 underwent high‐resolution anoscopy (HRA) and biopsy. Cancer registry data were queried. Predictors of abnormal cytology (ie, ≥ASCUS) and histological high‐grade squamous intraepithelial lesions (HSIL) were evaluated using unadjusted logistic regression models. Median age was 28 years (range, 18‐34). 19% received at least one dose of HPV vaccine. Abnormal cytology rate was 65%. HR‐HPV and HPV16 prevalence were 87% and 30%. Biopsy results were benign (10%), LSIL (43%) and HSIL (47%). No cases of prevalent or incident anal cancers were detected. Findings were similar between age subgroups (18‐24, 25‐29 and 30‐34) except for a higher prevalence of AIN 3 in the 30‐34 group (19%). Abnormal cytology was significantly associated with HR‐HPV infection. Histological HSIL was associated with HR‐HPV infection and cytological LSIL or worse. The absence of anal cancer in a large cohort of MSM LWH under the age of 35, despite high prevalence of anal HR‐HPV infection and precancer, supports an age‐based anal cancer screening strategy for MSM LWH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Department of Surgery, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
ORCID-Profile: Yuxin Liu
Förderung
- NCI NIH HHS
- NCATS NIH HHS
- Division of Cancer Prevention, National Cancer Institute
Zitieren
APA
Liu, Y., Bhardwaj, S., Sigel, K., Winters, J., Terlizzi, J., & Gaisa, M. M. (2024). Anal cancer screening results from 18‐to‐34‐year‐old men who have sex with men living with HIV. International Journal of Cancer. https://doi.org/10.1002/ijc.34734
Vancouver
Liu Y, Bhardwaj S, Sigel K, Winters J, Terlizzi J, Gaisa MM. Anal cancer screening results from 18‐to‐34‐year‐old men who have sex with men living with HIV. International Journal of Cancer. 2024. doi:10.1002/ijc.34734
BibTeX
@article{Liu2024,
author = {Liu, Yuxin and Bhardwaj, Swati and Sigel, Keith and Winters, John and Terlizzi, Joseph and Gaisa, Michael M},
title = {Anal cancer screening results from 18‐to‐34‐year‐old men who have sex with men living with HIV},
journal = {International Journal of Cancer},
year = {2024},
doi = {10.1002/ijc.34734}
}
EUVIMED